The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Drynol 2.5 mg/ml oral solution

2.5 milligram(s)/millilitre Oral solution

Menarini International Operations Luxembourg S.A.PA0865/018/003

Main Information

Trade NameDrynol 2.5 mg/ml oral solution
Active SubstancesBilastine
Strength2.5 milligram(s)/millilitre
Dosage FormOral solution
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/018/003

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX29 bilastine

Status

Authorised/WithdrawnAuthorised
Licence Issued14/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back